Prostate cancer decisions — 2024

The Veteran's service-connected disabilities alone have not rendered him unable to secure and follow substantially gainful employment.

The Board has remanded the claims of service connection for an acquired psychiatric disorder, a peri-anal cyst, and prostate cancer due to additional procedural development being required.

The Board denied service connection for prostate cancer, a skin condition, and diabetes. The Veteran's prostate cancer was not linked to his in-service exposure due to asbestos, and the skin conditions were not related to his TERA. Diabetes is not service-connected as there is no evidence of it during service.

The Board denied the Veteran's claims for service connection for prostate cancer and erectile dysfunction, finding that there was no evidence of herbicide exposure or a relationship to service.

The Board has remanded the case due to inadequate opinions regarding the Veteran's prostate cancer and its relation to his exposure at Camp Lejeune. The Veteran's claim is being reconsidered with a new toxic exposure risk activity (TERA) opinion.

The Veteran's cause of death, senile brain degeneration, was not related to his military service. The Board found no evidence that the Veteran's prostate cancer or bladder cancer were caused by or contributed to his death.

The Veteran's service connection for prostate cancer is granted due to his exposure to herbicides during his service in the Republic of Vietnam.

The Board has found that the Veteran's claims for service connection for back condition and prostate cancer require further development due to incomplete medical opinions and unverified exposure claims.

The Board has remanded the claims of service connection for prostate cancer, bilateral hearing loss, an acquired psychiatric disorder, and tinnitus due to incomplete records from VA treatment centers. The AOJ is instructed to obtain all relevant records and readjudicate the cases.

The Board denied service connection for colon cancer and prostate cancer, finding that the evidence did not support a link to service. The cause of death was also denied.,There is no indication of exposure to Agent Orange or other herbicides during service.

The Board has remanded the Veteran's claims for service connection due to exposure to herbicide agents, including for rheumatoid arthritis, right hip degenerative joint disease and acetabular cyst status post total hip replacement, osteoarthritis or unspecified joints, psoriatic arthritis, hypertension, prostate cancer, diabetes mellitus type II, compromised immune system, fever sores, and enlarged liver. The remand requires additional development to address the Veteran's exposure to chemicals during his duties as a missile crewman.

The Veteran's prostate cancer is remanded due to the need for a VA medical opinion regarding exposure to asbestos and lead-based paint during service, as well as verification of such exposure. The claim will be adjudicated again after these additional developments.

The Board has granted service connection for residuals of prostate cancer, finding that the Veteran's exposure to contaminated water at Camp Lejeune is etiologically related to his prostate cancer.

The Board has remanded the issue of service connection for prostate cancer, including as due to Agent Orange exposure, due to insufficient evidence regarding in-service herbicide exposure at Clark Air Force Base.

The Board denied the Veteran's claims for service connection for prostate cancer, hypertrophy (benign) of prostate, erectile dysfunction, and voiding dysfunction due to a lack of evidence showing these conditions began during service or were related to an in-service injury or disease.

The Board has denied a TDIU prior to March 2, 2018 and remanded the issue of an increased rating for prostate cancer residuals.

The Board has remanded the claims for service connection due to insufficient evidence and need for further medical examination. The appellant is seeking service connection for various conditions, including hearing loss, tinnitus, atrial fibrillation, heart failure, amyloidosis, prostate cancer, Parkinson's disease, and cortico basal degeneration, all potentially related to in-service exposure to toxins.

The Board has remanded the cases for further examination and opinion regarding service connection for vitiligo and prostate cancer due to exposure at Camp Lejeune. The Veteran's claims are based on a presumption of exposure.

The Board denied service connection for prostate cancer as there was no evidence showing the Veteran's prostate cancer began during or within one year of his military service, and there was no credible evidence linking it to herbicide exposure in Vietnam.

The Veteran's appeal for special monthly compensation (SMC) based on housebound status or need for regular aid and attendance prior to December 14, 2019 was denied as his service-connected disabilities did not render him so helpless that he required regular assistance.